EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pre-ICU statin therapy reduces 28-day mortality in sepsis-associated brain dysfunction: a propensity-matched analysis of potential neuroprotective mechanisms

Prä-ICU-Statintherapie senkt die 28-Tage-Mortalität bei sepsisassoziierter Hirndysfunktion: Propensity-Matched-Analyse möglicher neuroprotektiver Mechanismen

Lei Yu, Shan Zou, Sihao Zheng, Jiangtao Deng, Qingshan Zhou, Jun Jin

Frontiers in Pharmacology · 30.09.2025 · 16

DOI: 10.3389/fphar.2025.1586372 ↗

Auf einen Blick

In einer retrospektiven Kohortenstudie war eine Statintherapie vor der ICU mit höherer 28-Tage-Überlebensrate bei SABD assoziiert. Der Effekt blieb in der adjustierten Analyse bestehen.

Fragestellung

Ist eine Statintherapie vor ICU-Aufnahme bei Patient:innen mit sepsisassoziierter Hirndysfunktion mit besseren klinischen Outcomes verbunden?

Methode

Retrospektive Kohortenstudie mit MIMIC-IV-Datenbank; Erwachsene mit Sepsis-3.0 und SABD; PSM 1:1 und Cox-Regression.

Ergebnisse

1.463 geeignete Patient:innen, davon 412 mit prä-ICU-Statinen. Nach PSM 374 vs. 374. 28-Tage-Überleben 91 % vs. 85 %; HR 0,604 (95 %-KI 0,380–0,960), P = 0,033.

Einschränkungen

Retrospektives Design.

Schlussfolgerung der Autor:innen

Eine Statintherapie vor der ICU war mit verbessertem 28-Tage-Überleben bei SABD assoziiert; prospektive randomisierte Studien seien zur Bestätigung erforderlich.

Kernaussagen

  • 28-Tage-Überleben: 91 % vs. 85 %
  • HR 0,604 (95 %-KI 0,380–0,960)
  • Sekundäre Endpunkte zeigten nur nicht signifikante Trends

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 30.09.2025. Verfasst von Lei Yu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Intensive Care Unit, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shenzhen Research and Development Program, Guangdong Medical Research Foundation.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Sepsis-associated brain dysfunction (SABD) is a severe complication of sepsis characterized by acute cognitive impairment and altered mental status, contributing to increased morbidity and mortality in intensive care units (ICUs). The pathophysiology involves neuroinflammation, oxidative stress, and blood-brain barrier disruption. Despite evidence suggesting potential anti-inflammatory and antioxidative properties of statins, their neuroprotective effects in SABD patients remain poorly characterized.

Methods

This retrospective cohort study utilized the MIMIC-IV database (version 3.1), including adult ICU patients meeting Sepsis-3.0 criteria and diagnosed with SABD, defined as Glasgow Coma Scale (GCS) score <15 or presence of delirium. Patients with preexisting neurological disorders, chronic alcohol/substance abuse, or severe metabolic imbalances were excluded. Pre-ICU statin use was identified through prescription records. Propensity score matching (PSM) at a 1:1 ratio was performed to balance baseline characteristics between pre-ICU statin users (n = 374) and non-users (n = 374). The primary outcome was 28-day all-cause mortality, with secondary outcomes including ICU mortality, in-hospital mortality, and length of stay. Kaplan-Meier survival analysis and Cox proportional hazards regression models were utilized to assess associations between pre-ICU statin use and clinical outcomes.

Results

Among 1,463 eligible patients, 412 (28.2%) received pre-ICU statin therapy. After PSM, baseline characteristics were well-balanced between groups. Kaplan-Meier analysis demonstrated significantly higher 28-day survival rates among statin users (91% vs. 85%; P = 0.0051). Cox regression demonstrated that pre-ICU statin use was independently associated with reduced 28-day mortality (HR: 0.604, 95% CI: 0.380–0.960, P = 0.033). Subgroup analyses revealed consistent protective effects in patients aged ≥65 years, males, those requiring vasopressors, and those on mechanical ventilation. Sensitivity analyses confirmed the robustness of these findings. Secondary outcomes showed trends toward reduced ICU mortality and shorter ICU stays in statin users, though these associations did not reach statistical significance after adjustment.

Conclusion

Pre-ICU statin therapy was associated with improved 28-day survival in SABD patients, potentially attributable to anti-inflammatory and antioxidant mechanisms. Despite limitations inherent in its retrospective design, this study suggests that statins may represent a promising therapeutic option for SABD patients. Prospective randomized controlled trials are warranted to validate these findings and optimize treatment protocols for this vulnerable population.

Schlagwörter

Stichwörter der Autor:innen

intensive careneuroinflammationoxidative stressretrospective cohort studysepsis-associated brain dysfunctionstatinssurvival

Autor:innen und Institutionen

  • Department of Intensive Care Unit, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China.

Förderung

  • Shenzhen Research and Development Program
  • Guangdong Medical Research Foundation

Zitieren

APA

Yu, L., Zou, S., Zheng, S., Deng, J., Zhou, Q., & Jin, J. (2025). Pre-ICU statin therapy reduces 28-day mortality in sepsis-associated brain dysfunction: a propensity-matched analysis of potential neuroprotective mechanisms. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1586372

Vancouver

Yu L, Zou S, Zheng S, Deng J, Zhou Q, Jin J. Pre-ICU statin therapy reduces 28-day mortality in sepsis-associated brain dysfunction: a propensity-matched analysis of potential neuroprotective mechanisms. Frontiers in Pharmacology. 2025;16. doi:10.3389/fphar.2025.1586372

BibTeX
@article{Yu2025,
  author = {Yu, Lei and Zou, Shan and Zheng, Sihao and Deng, Jiangtao and Zhou, Qingshan and Jin, Jun},
  title = {Pre-ICU statin therapy reduces 28-day mortality in sepsis-associated brain dysfunction: a propensity-matched analysis of potential neuroprotective mechanisms},
  journal = {Frontiers in Pharmacology},
  year = {2025},
  volume = {16},
  doi = {10.3389/fphar.2025.1586372}
}
Kostenlos starten →